These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 29085492)
21. Immunohistochemical localization of the IAP protein survivin in bladder mucosa and transitional cell carcinoma. Lehner R; Lucia MS; Jarboe EA; Orlicky D; Shroyer AL; McGregor JA; Shroyer KR Appl Immunohistochem Mol Morphol; 2002 Jun; 10(2):134-8. PubMed ID: 12051631 [TBL] [Abstract][Full Text] [Related]
22. Therapy-relevant aberrant expression of MRP3 and BCRP mRNA in TCC-/SCC-bladder cancer tissue of untreated patients. Rady M; Mostageer M; Rohde J; Zaghloul A; Knüchel-Clarke R; Saad S; Attia D; Mahran L; Spahn-Langguth H Oncol Rep; 2017 Jul; 38(1):551-560. PubMed ID: 28586062 [TBL] [Abstract][Full Text] [Related]
23. Frequent expression of zinc-finger protein ZNF165 in human urinary bladder transitional cell carcinoma. Singh PK; Srivastava AK; Dalela D; Rath SK; Goel MM; Bhatt ML Immunobiology; 2015 Jan; 220(1):68-73. PubMed ID: 25214475 [TBL] [Abstract][Full Text] [Related]
24. E-cadherin tissue expression and urinary soluble forms of E-cadherin in patients with bladder transitional cell carcinoma. Shi B; Laudon V; Yu S; Dong D; Zhu Y; Xu Z Urol Int; 2008; 81(3):320-4. PubMed ID: 18931551 [TBL] [Abstract][Full Text] [Related]
25. Expression of prostate-specific membrane antigen in transitional cell carcinoma of the bladder: prognostic value? Gala JL; Loric S; Guiot Y; Denmeade SR; Gady A; Brasseur F; Heusterspreute M; Eschwège P; De Nayer P; Van Cangh P; Tombal B Clin Cancer Res; 2000 Oct; 6(10):4049-54. PubMed ID: 11051255 [TBL] [Abstract][Full Text] [Related]
26. Expression profile of cancer-testis genes in transitional cell carcinoma of the bladder. Yin B; Liu G; Wang XS; Zhang H; Song YS; Wu B Urol Oncol; 2012; 30(6):886-92. PubMed ID: 21396841 [TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of hepatoma-up-regulated protein expression in patients with urinary bladder transitional cell carcinoma. Huang YL; Chiu AW; Huan SK; Wang YC; Ju JP; Lu CL Anticancer Res; 2003; 23(3B):2729-33. PubMed ID: 12894566 [TBL] [Abstract][Full Text] [Related]
28. The Immune Checkpoint Molecule CD200 Is Associated with Tumor Grading and Metastasis in Bladder Cancer. Rexin P; Tauchert A; Hänze J; Heers H; Schmidt A; Hofmann R; Hegele A Anticancer Res; 2018 May; 38(5):2749-2754. PubMed ID: 29715095 [TBL] [Abstract][Full Text] [Related]
29. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas. Kunze E; Wendt M; Schlott T Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403 [TBL] [Abstract][Full Text] [Related]
30. Expression profile of Zhang XY; Yan QX; Guo XY; Chen CR; Chen RQ; Cai ZM; Tang AF Oncol Lett; 2016 Nov; 12(5):3731-3738. PubMed ID: 27895724 [TBL] [Abstract][Full Text] [Related]
31. Novel somatic mutations identified by whole-exome sequencing in muscle-invasive transitional cell carcinoma of the bladder. Pan H; Xu X; Wu D; Qiu Q; Zhou S; He X; Zhou Y; Qu P; Hou J; He J; Zhou J Oncol Lett; 2016 Feb; 11(2):1486-1492. PubMed ID: 26893765 [TBL] [Abstract][Full Text] [Related]
32. Relationship between cysteinyl-leukotriene-1 receptor and human transitional cell carcinoma in bladder. Matsuyama M; Funao K; Hayama T; Tanaka T; Kawahito Y; Sano H; Takemoto Y; Nakatani T; Yoshimura R Urology; 2009 Apr; 73(4):916-21. PubMed ID: 19167045 [TBL] [Abstract][Full Text] [Related]
33. Wild-type p53-induced phosphatase 1 is a prognostic marker and therapeutic target in bladder transitional cell carcinoma. Wang ZP; Chen SY; Tian Y Oncol Lett; 2017 Feb; 13(2):875-880. PubMed ID: 28356972 [TBL] [Abstract][Full Text] [Related]
34. Long noncoding RNA HOTAIR is a prognostic biomarker and inhibits chemosensitivity to doxorubicin in bladder transitional cell carcinoma. Shang C; Guo Y; Zhang H; Xue YX Cancer Chemother Pharmacol; 2016 Mar; 77(3):507-13. PubMed ID: 26781446 [TBL] [Abstract][Full Text] [Related]
35. Expression of chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) in bladder transitional cell carcinoma. Ham WS; Lee JH; Yu HS; Choi YD Urology; 2008 Oct; 72(4):921-6. PubMed ID: 18387660 [TBL] [Abstract][Full Text] [Related]
36. [Expression of cyclooxygenase-2 in bladder transitional cell carcinoma and the significance thereof]. Yu L; Chen XJ; Shi PQ; Ding Q; Sun CH; Liu GB; Shi DM; Huang YG Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(38):2683-4. PubMed ID: 19080686 [TBL] [Abstract][Full Text] [Related]
37. High expression of human uroplakin Ia in urinary bladder transitional cell carcinoma. Kageyama S; Yoshiki T; Isono T; Tanaka T; Kim CJ; Yuasa T; Okada Y Jpn J Cancer Res; 2002 May; 93(5):523-31. PubMed ID: 12036448 [TBL] [Abstract][Full Text] [Related]
38. [Expression of Survivin in transitional cell carcinoma of urinary bladder and its clinical significance]. Xiao ZJ; Zheng S; Chen W; Zhang HF; Li CL; Gao YN Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(23):1977-9. PubMed ID: 15730809 [TBL] [Abstract][Full Text] [Related]
39. Loss of FHIT expression in transitional cell carcinoma of the urinary bladder. Baffa R; Gomella LG; Vecchione A; Bassi P; Mimori K; Sedor J; Calviello CM; Gardiman M; Minimo C; Strup SE; McCue PA; Kovatich AJ; Pagano F; Huebner K; Croce CM Am J Pathol; 2000 Feb; 156(2):419-24. PubMed ID: 10666370 [TBL] [Abstract][Full Text] [Related]
40. Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance. Shen SS; Lerner SP; Muezzinoglu B; Truong LD; Amiel G; Wheeler TM Hum Pathol; 2006 Jun; 37(6):726-34. PubMed ID: 16733214 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]